Article, Interview Reid Robison, MD MBA 11/18/23 Article, Interview Reid Robison, MD MBA 11/18/23

Smithsonian Magazine: Are psychedelics the future of eating disorder treatment?

Read More

Article, Interview Reid Robison, MD MBA 10/9/23 Article, Interview Reid Robison, MD MBA 10/9/23

Tricycle Day: Psychonaut POV — Q&A with Reid Robison

Read More

Article, Interview Reid Robison, MD MBA 8/18/23 Article, Interview Reid Robison, MD MBA 8/18/23

Everyday Health: What is ketamine therapy? A detailed scientific guide

Read More

Article Reid Robison, MD MBA 8/8/23 Article Reid Robison, MD MBA 8/8/23

Forbes Health: Ketamine for depression — Does it work?

Read More

Article Reid Robison, MD MBA 7/3/23 Article Reid Robison, MD MBA 7/3/23

Salt Lake Tribune: Utah failed to legalize psilocybin—but local research, and an underground scene, is booming

Read More

Article Reid Robison, MD MBA 5/31/23 Article Reid Robison, MD MBA 5/31/23

Forbes: With pressure to scale, some ketamine clinics could be doing harm. Here’s what consumers need to know.

Read More

Article Reid Robison, MD MBA 4/7/23 Article Reid Robison, MD MBA 4/7/23

Cosmpolitan: On the front line of the eating disorder epidemic

Read More

Article, Interview Reid Robison, MD MBA 11/30/22 Article, Interview Reid Robison, MD MBA 11/30/22

Daily Hive: We asked an expert to explain psychedelic-assisted therapy

Read More

Article Reid Robison, MD MBA 11/18/22 Article Reid Robison, MD MBA 11/18/22

Salt Lake Tribune: A framework for safe access to psychotherapeutic medicine in Utah

Read More

Interview, Article Reid Robison, MD MBA 9/14/22 Interview, Article Reid Robison, MD MBA 9/14/22

Healing Maps: Psychedelics for eating disorders

Read More

Article Reid Robison, MD MBA 7/13/22 Article Reid Robison, MD MBA 7/13/22

Kind Magazine: What a long, strange trip it’s been

Read More

Article Reid Robison, MD MBA 3/4/22 Article Reid Robison, MD MBA 3/4/22

Psychedelic Health: Psychedelics for frontline workers, palliative care & eating disorders

Read More

Article Reid Robison, MD MBA 2/9/22 Article Reid Robison, MD MBA 2/9/22

Psychiatric Times: Psychedelics & the future of psychiatry

Read More

Article Reid Robison, MD MBA 1/17/22 Article Reid Robison, MD MBA 1/17/22

Mental Health Weekly: Psychedelic therapies continue to be seen as big trend in MH treatment

Read More

Article Reid Robison, MD MBA 11/22/21 Article Reid Robison, MD MBA 11/22/21

Bezinga: Psychedelic companies keenly aware of creating therapies as healthcare reimbursement possibility looms

Read More

Article, Interview Reid Robison, MD MBA 11/9/21 Article, Interview Reid Robison, MD MBA 11/9/21

Psychedelia Magazine: A beginner’s guide to psychedelics

Read More

Article Reid Robison, MD MBA 10/13/21 Article Reid Robison, MD MBA 10/13/21

Technology Networks: Exploring the combination of psychedelics and psychotherapy

Read More

Article Reid Robison, MD MBA 8/6/21 Article Reid Robison, MD MBA 8/6/21

Leafly: How ketamine is transforming mental health

Read More

Article Reid Robison, MD MBA 7/29/21 Article Reid Robison, MD MBA 7/29/21

Novamind opens 5th clinic location

Read More

Article Reid Robison, MD MBA 7/26/21 Article Reid Robison, MD MBA 7/26/21

Business Insider: Top psychedelics VCs predict a tech boom and a rise of clinics over the next year

Read More